Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| EB Epicrispr BiotechnologiesCompany profile Develops programmable epigenetic medicines to treat genetic diseases like FSHD Develops programmable epigenetic medicines to treat genetic diseases like FSHD | $90M | Series CSeries C+ | Biotech | United States | Investors |
Ranked by rounds participated in · All time
AusperBio, Abcuro, Infinimmune
Epicrispr Biotechnologies, Draig Therapeutics, Triveni Bio
LifeMine Therapeutics, Ollin Biosciences, SonoThera
Leal Therapeutics, Khartis Therapeutics, Vedana Therapeutics
Leal Therapeutics, Amplifica Holdings Group, InduPro
Explore published rounds while the next edition is being prepared.
| AB Aureka BiotechnologiesCompany profile Builds biological foundation models and closed-loop infrastructure for drug discovery Builds biological foundation models and closed-loop infrastructure for drug discovery | $100M | Series B | Biotech | United States | Investors |
| RB Remedium BioCompany profile Develops durable protein therapeutics via gene therapy for chronic diseases Develops durable protein therapeutics via gene therapy for chronic diseases | $10M | Series A | Biotech | United States | Investors |
| S SkinBitCompany profile Provides full-body skin scanning technology for early skin cancer detection and screening Provides full-body skin scanning technology for early skin cancer detection and screening | $6M | Pre-SeedPre-seed | Biotech, Healthtech | United States | Investors |
| LT LifeMine TherapeuticsCompany profile Develops fungal genome-derived therapeutics for organ transplant rejection Develops fungal genome-derived therapeutics for organ transplant rejection | $263M | Series D+Series EUndisclosed | Biotech | United States | Investors |
| VB Vedanta BiosciencesCompany profile Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection | $60M | Growth | Biotech | United States | Investors |
| Q QuantHealthCompany profile AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment | $45M | Series B | Biotech | Israel | Investors |
| CL CND Life SciencesCompany profile Develops biomarker-based diagnostic tests for neurodegenerative diseases Develops biomarker-based diagnostic tests for neurodegenerative diseases | Undisclosed | Growth | Biotech | United States | Investors |
| C Uses genomic surveillance to identify hospital infection outbreaks and sources | $3.5M | Pre-SeedPre-seed | Biotech | United States | Investors |
| I Whole-genome sequencing and bioinformatics platform for precision oncology | $31M | Series B | Biotech | United States | Investors |